Cor Vasa 2024, 66(5):525-528 | DOI: 10.33678/cor.2024.033

Time to change the family diagnosis: Arrhythmogenic left ventricular cardiomyopathy

Michaela Veseláa, Gabriela Dostálováa, Zuzana Hlubockáa, Petr Kuchynkaa, Vladimír Tukaa, Tomáš Kovárníka, Martin Mašekb, Aleš Linharta
a 2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, the Czech Republic
b Department of Radiology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, the Czech Republic

Arrhythmogenic cardiomyopathy is an inherited cardiomyopathy characterized by fibrofatty replacement and a high risk of ventricular arrhythmias and sudden cardiac death. This myocardial disorder is typically transmitted through autosomal dominant pattern and caused by pathogenic variants in the desmosomal and extradesmosomal genes. In this case, we are presenting a family with three members who have arrhythmogenic left ventricular cardiomyopathy. The condition was found to be caused by a nonsense mutation (c.1754 T>G (p. Leu585Ter)) in the desmoplakin (DSP) gene. Unfortunately, two of the family members were initially misdiagnosed and treated for coronary artery disease, which was not the correct diagnosis. This case demonstrates the importance of accurate differential diagnosis and the usefulness of magnetic resonance imaging (MRI) in establishing the correct diagnosis of arrhythmogenic cardiomyopathy.

Keywords: Arrhythmogenic cardiomyopathy, Desmoplakin, Late gadolinium enhancement, Misdiagnose, Myocardial infarction with non-obstructive coronary arteries

Received: March 20, 2024; Revised: March 20, 2024; Accepted: April 22, 2024; Prepublished online: June 2, 2012; Published: October 25, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Veselá M, Dostálová G, Hlubocká Z, Kuchynka P, Tuka V, Kovárník T, et al.. Time to change the family diagnosis: Arrhythmogenic left ventricular cardiomyopathy. Cor Vasa. 2024;66(5):525-528. doi: 10.33678/cor.2024.033.
Download citation

References

  1. Gasior P, Desperak A, Gierlotka M, et al. Clinical Characteristics, Treatments, and Outcomes of Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA): Results from a Multicenter National Registry. J Clin Med 2020;9:2779. Go to original source... Go to PubMed...
  2. Dreyer RP, Sciria C, Spatz ES, et al. Young Women With Acute Myocardial Infarction: Current Perspectives. Circ Cardiovasc Qual Outcomes 2017;10:e003480. Go to original source... Go to PubMed...
  3. Vaccarino V. Myocardial Infarction in Young Women. Circulation 2019;139:1057-1059. Go to original source... Go to PubMed...
  4. Patel V, Asatryan B, Siripanthong B, et al. State of the Art Review on Genetics and Precision Medicine in Arrhythmogenic Cardiomyopathy. Int J Mol Sci 2020;21:6615. Go to original source... Go to PubMed...
  5. Austin KM, Trembley MA, Chandler SF, et al. Molecular mechanisms of arrhythmogenic cardiomyopathy. Nature reviews. Cardiology 2019;16:519-537. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.